Richard J. Wallace's most recent trade in Immunogen, Inc. was a trade of 19,597 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunogen Inc | Richard J. Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 19,597 | 19,597 | - | - | Stock Option (right to buy) | |
| Immunogen Inc | Richard J. Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 13,090 | 13,090 | - | - | Restricted Stock Unit | |
| Immunogen Inc | Richard J. Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Immunogen Inc | Richard J. Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 102,326 | - | - | Deferred Share Unit | |
| Immunogen Inc | Richard J. Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Immunogen Inc | Richard J. Wallace | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 15,000 | 87,326 | - | - | Deferred Share Unit |